secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001493152-25-006139
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amends $20M patent deal to credit R&D costs; raises $710K via stock sales
-------------------------------------------------------------------------

- Amends Patent Purchase Agreement; cash payments reduced to $306K from $373K as of Dec 31, 2024.
- Issued 155,555 shares at $2.25/share for $350K to accredited investor in private placement.
- Received $210K from exercise of 140,000 warrants at $1.50/share on Feb 10.
- Received $150K from exercise of 100,000 warrants at $1.50/share on Feb 11.
- Series B Preferred converted 216 shares (stated value $237,600) into 105,600 common shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225006139/0001493152-25-006139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225006139/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer